Drug Discovery & Development takes a look at progress and practicalities in the first generation of stem cell therapies: "But exactly how does it all work? That's a critical question about cardiac regeneration using stem cells, and one that scientists don't yet have the answer to. They have theories, some more popular than others. ... In randomized trials in Europe, 70% to 80% of people got better. ... Are all patients who get stem cells going to get better? No. Just like with any other therapy, you have to select your patients correctly, and we're continually refining which patients may benefit. ... Right now, it's a little bit of the Wild Wild West out there, and there's a lot of hucksterism. It's hard to know what to believe and what not to. But I'm very bullish on this. I think the field of regenerative therapy will change the practice of cardiology as we know it." Early days yet.

Link: http://www.dddmag.com/ShowPR~PUBCODE~016~ACCT~1600000100~ISSUE~0611~RELTYPE~CVS~ProdCode~00000000~PRODLETT~X.html